-
Media Room Article
The 2024 Impact Report of the Cancer Research Institute
Executive Summary Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront… -
Media Room Article
Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations
NEW YORK – August 8, 2024 — As the leading nonprofit organization committed to revolutionizing cancer treatment… -
Media Room Article
Cancer Research Institute Announces New Lloyd J. Old STARs Class
New York, NY – August 5, 2024 – The Cancer Research Institute (CRI) proudly announces the newest… -
Media Room Article
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer
REDWOOD CITY, Calif., May 8, 2024 — Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the… -
Media Room Article
New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer
Survey examined oncologists’ perspective on treatment options and priorities, comorbidities and other clinical characteristics of patients with… -
Media Room Article
CRI CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey on Immunotherapy and Her Tenure
NEW YORK – Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute… -
Media Room Article
Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell
Contact: Melinda Koski, SouthPoleTrek4Cancer Sharon Slade, Chief Marketing Officer, CRI For Immediate Release Tuesday, December 19, 2023… -
Media Room Article
The Cancer Research Institute’s Patient Immunotherapy Summit is Now Available On Demand
NEW YORK — The Cancer Research Institute (CRI) is excited to announce the premiere of the seventh… -
Media Room Article
CRI CEO Dr. Jill O’Donnell-Tormey on How Data Drives Immunotherapy Advances
New York, November 22, 2023 Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs…
